Clinical Trial Update: Phase 2 Study of KHK4577 [Phase 2]

View source ↗

Summary

Phase 2 study of KHK4577 for atopic dermatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• KHK4577

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED